Chlorpheniramine and Buprenorphine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Chlorpheniramine
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Buprenorphine is a strong pain and opioid-use medicine, and chlorpheniramine is an older antihistamine (found in many allergy and cold products). Taken together, two things can add up. First, both can nudge up the body chemical serotonin, which in rare cases can cause serotonin syndrome (things like agitation, sweating, fast heartbeat, shivering, or twitching). Second, both can slow the gut and cause serious constipation, which very rarely can lead to a blocked bowel.
This concern is mostly theoretical, so please don't panic. Keep taking both as prescribed and let your care team know you take them together, they can watch you closely and manage this easily.
Additive risk, theoretical. Coadministration of buprenorphine (opioid partial agonist with serotonergic activity) and chlorpheniramine (sedating antihistamine with anticholinergic properties) may produce two additive effects:
- Serotonergic: additive serotonin activity, raising theoretical risk of serotonin syndrome.
- GI/anticholinergic: additive reduction in gastric motility, increasing risk of severe constipation, urinary retention, and rarely paralytic ileus.
Onset: unspecified. Evidence: theoretical. Neither drug's activation depends on the other. Management: use with caution, monitor especially at initiation and dose changes, counsel on bowel regimen, and discontinue if serotonin syndrome is suspected.
What happens
An increased risk of serotonin syndrome and an increased risk of paralytic ileus
Interaction Deep Dive
When buprenorphine is given together with serotonergic drugs, such as SSRIs, serotonin and norepinephrine reuptake inhibitors, tricyclic antidepressants, triptans, 5-HT3 receptor antagonists, agents that interfere with serotonin metabolism, and other substances acting on the serotonergic system, serotonin syndrome may develop. Watch for indications of severe constipation, since this can progress to paralytic ileus. Should combined use of buprenorphine and serotonergic agents that possess anticholinergic properties be required, monitor the patient, particularly when therapy is being started and when doses are being adjusted231.
Why it happens (mechanism)
Additive serotonergic effects; additive effects on gastric motility
How to manage this interaction
Keep taking both exactly as prescribed unless your prescriber tells you otherwise. Your care team can manage this by watching you more closely, especially when either drug is started or the dose is changed.
- Watch for serotonin syndrome: agitation, confusion, fast heartbeat, sweating, shivering, muscle twitching. Seek help promptly if these appear.
- Watch for severe constipation or trouble urinating. Ask your team about fluids, fiber, or a stool softener.
- Tell your pharmacist and prescriber you take these together so they can decide if a dose should be adjusted and individualized, or an alternative antihistamine chosen.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Chlorpheniramine and Buprenorphine together?
Taking buprenorphine with chlorpheniramine can add up to raise the (theoretical) risk of serotonin syndrome and of severe constipation. Keep taking both as prescribed, watch for those symptoms, and let your care team know so they can monitor you. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Chlorpheniramine and Buprenorphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Chlorpheniramine and Buprenorphine interaction managed?
Keep taking both exactly as prescribed unless your prescriber tells you otherwise. Your care team can manage this by watching you more closely, especially when either drug is started or the dose is changed. Watch for serotonin syndrome: agitation, confusion, fast heartbeat, sweating, shivering, muscle twitching. Seek help promptly if these appear. Watch for severe constipation or trouble urinating… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Chlorpheniramine or Buprenorphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (3)
- Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
- Product Information: BUTRANS(R) transdermal system patch, buprenorphine transdermal system patch. Purdue Pharma L.P. (per FDA), Stamford, CT, 2016. DailyMed
- Product Information: SUBOXONE(R) sublingual film, buprenorphine naloxone sublingual film. Indivior Inc (per FDA), Richmond, VA, 2017. DailyMed
Keep reading about Buprenorphine
Keep reading about Chlorpheniramine
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist